uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Determination of receptor protein binding site specificity and relative binding strength using a time-resolved competition assay
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Radiology, Oncology and Radiation Science, Biomedical Radiation Sciences.
Show others and affiliations
2014 (English)In: Journal of pharmacological and toxicological methods, ISSN 1056-8719, E-ISSN 1873-488X, Vol. 70, no 2, 145-151 p.Article in journal (Refereed) Published
Abstract [en]

Introduction: Competitive binding assays can be used to decipher not only the binding kinetics of studied ligands but also the binding site preference. Such assays are an essential step in the characterization of radioligands. However, the currently used competition assays require high concentrations of usually expensive ligands and still provide only binding site preference. By employing the time-resolved competition assay presented in this paper, binding characteristics including binding site preference can be obtained using less ligand. Methods: To demonstrate the appropriateness of the time-resolved competition assay, we developed an assay in which the ligand binding was interrupted with a competitor. Experiments were performed on human carcinoma cell lines expressing epidermal growth factor receptor (EGFR). The targeting of the receptor was performed with radio-iodinated epidermal growth factor (EGF). The employed competitors involved either natural ligand transforming growth factor alpha (TGF-alpha) or anti-EGFR antibodies cetuximab and panitumumab targeting the same EGFR domain. Results: Radio-iodinated EGF bound to EGFR was displaced with either low concentrations of cetuximab or high concentrations of panitumumab. In the case of TGF-alpha, we observed no competitive displacement of bound EGF at either high or low concentrations. When comparing the time-resolved competition assay with a manual competition assay, the resulting data of measured inhibition constants were in agreement. Discussion: The results summarised in this study confirm the appropriateness of the time-resolved competition assay for assessing ligand binding properties. The assay has the potential to complement or replace conventional competition assays for determining binding site preference in the future.  

Place, publisher, year, edition, pages
2014. Vol. 70, no 2, 145-151 p.
Keyword [en]
Binding assay, Cetuximab, Competition assay, EGF receptor, Methods, Panitumumab, TGF-alpha, Tracer, Competitor
National Category
Pharmacology and Toxicology
URN: urn:nbn:se:uu:diva-235187DOI: 10.1016/j.vascn.2014.07.006ISI: 000342158000003PubMedID: 25084055OAI: oai:DiVA.org:uu-235187DiVA: diva2:759461
Available from: 2014-10-30 Created: 2014-10-29 Last updated: 2014-10-30Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Spiegelberg, DianaAndersson, Karl
By organisation
Biomedical Radiation Sciences
In the same journal
Journal of pharmacological and toxicological methods
Pharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 180 hits
ReferencesLink to record
Permanent link

Direct link